Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.0 EUR
58.40 M EUR
1.12 B EUR
30.00 M
About CONMED Corporation
Sector
Industry
CEO
Curt R. Hartman
Website
Headquarters
Largo
Founded
1970
FIGI
BBG000GQH1Z5
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CONMED CORP. DL-,01 stocks are traded under the ticker EC8.
We've gathered analysts' opinions on CONMED CORP. DL-,01 future price: according to them, EC8 price has a max estimate of 93.94 EUR and a min estimate of 66.31 EUR. Watch EC8 chart and read a more detailed CONMED CORP. DL-,01 stock forecast: see what analysts think of CONMED CORP. DL-,01 and suggest that you do with its stocks.
Yes, you can track CONMED CORP. DL-,01 financials in yearly and quarterly reports right on TradingView.
CONMED CORP. DL-,01 is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
EC8 earnings for the last quarter are 0.94 EUR per share, whereas the estimation was 0.92 EUR resulting in a 2.63% surprise. The estimated earnings for the next quarter are 1.14 EUR per share. See more details about CONMED CORP. DL-,01 earnings.
CONMED CORP. DL-,01 revenue for the last quarter amounts to 284.44 M EUR, despite the estimated figure of 285.41 M EUR. In the next quarter, revenue is expected to reach 321.06 M EUR.
EC8 net income for the last quarter is 43.99 M EUR, while the quarter before that showed 27.99 M EUR of net income which accounts for 57.20% change. Track more CONMED CORP. DL-,01 financial stats to get the full picture.
Yes, EC8 dividends are paid quarterly. The last dividend per share was 0.18 EUR. As of today, Dividend Yield (TTM)% is 1.07%. Tracking CONMED CORP. DL-,01 dividends might help you take more informed decisions.
As of Nov 13, 2024, the company has 4.00 K employees. See our rating of the largest employees — is CONMED CORP. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONMED CORP. DL-,01 EBITDA is 194.08 M EUR, and current EBITDA margin is 14.68%. See more stats in CONMED CORP. DL-,01 financial statements.
Like other stocks, EC8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONMED CORP. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.